Search

Your search keyword '"Steinsnyder, Zoe"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Steinsnyder, Zoe" Remove constraint Author: "Steinsnyder, Zoe"
36 results on '"Steinsnyder, Zoe"'

Search Results

1. Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment

2. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

3. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

4. P-354 Whole genome sequencing reveals significant genetic admixture in multiple myeloma patients, impacting assessment of etiology

5. Abstract 5709: Whole genome error-corrected sequencing for sensitive circulating tumor DNA cancer monitoring

6. Figure S2 from NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects

7. Supplementary Table S7 from Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

8. Supplementary Tables S2-S5 from Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

9. Supplementary Data from Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

10. Whole genome error-corrected sequencing for sensitive circulating tumor DNA cancer monitoring

11. NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects

13. Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring

14. Author Correction : A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

15. SNPs at SMG7 Associated with Time from Biochemical Recurrence to Prostate Cancer Death.

16. Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

17. Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants

18. Characterization of the Cancer Spectrum in Men with Germline BRCA1 and BRCA2 Pathogenic Variants:Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

19. Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

20. Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening

22. Pathogenic Loss-of-Function Germline TERT Mutations in Patients With Solid Tumors

23. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1and BRCA2pathogenic variants

24. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

25. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

26. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

27. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

28. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

29. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

30. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

31. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

32. Development and extensive sequencing of a broadly-consented Genome in a Bottle matched tumor-normal pair.

33. NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects.

34. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

35. Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer.

36. Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Catalog

Books, media, physical & digital resources